牛支原体疫苗的研究进展

doi:10.16431/j.cnki.1671-7236.2018.03.026

摘要/Abstract

摘要：

牛支原体（Mycoplasma bovis，M.bovis）是一种造成全世界范围内育肥牛和奶牛多种疾病综合征的重要病原体。临床症状主要包括长期性肺炎及多发性关节炎（CPPS）、呼吸道疾病综合征（BRD）、乳腺炎及生殖器官疾病。牛支原体能感染多种组织和器官，也能从健康的牛体内分离，是威胁畜牧业生产的主要病原体。由于临床上抗生素治疗效果不佳，预防或控制牛支原体感染最好的选择是研发有效的商业可用的疫苗。牛支原体疫苗的研究已历经多年，虽然存在很多问题，但也取得了一定进展。文章对牛支原体弱毒疫苗、灭活疫苗及亚单位疫苗的研究进展进行了总结，并讨论了疫苗设计的优化方案，为合理设计和研发有效的牛支原体防控技术提供参考。

关键词: 牛支原体; 弱毒疫苗; 灭活疫苗; 亚单位疫苗

Abstract:

Mycoplasma bovis (M.bovis) is a pathogen that causes a variety of diseases in beef cattle and dairy cows around the world.Clinical symptoms include chronic pneumonia and polyarthritis syndrome (CPPS),bovine respiratory disease complex (BRD),mastitis and genital disorders.M.bovis can infect a variety of tissues and organs,and can also be isolated from healthy cattle.It is the major causative agent that threatens livestock production.Due to the resistance to antibiotic therapy,the best option of preventing and controlling the infection of M.bovis is to develop effective commercially available vaccines.The research on the vaccine of M.bovis has been going on for many years.Despite some problems,the M.bovis vaccines have made some good progress.In this paper,the advances on the research of attenuated vaccines,inactivated vaccines and subunit vaccines against M.bovis were summarized,and the optimization plan of vaccines design were discussed,which could provide reference for the rational design and development of effective M.bovis control techniques.

Key words: Mycoplasma bovis; attenuated vaccine; inactivated vaccine; subunit vaccine

中图分类号:

S858.23

季文恒, 吴娅琴, 翟肖辉, 储岳峰. 牛支原体疫苗的研究进展[J]. 《中国畜牧兽医》, 2018, 45(3): 763-769.

JI Wenheng, WU Yaqin, ZHAI Xiaohui, CHU Yuefeng. Advances on the Research of Vaccine Against Mycoplasma bovis[J]. , 2018, 45(3): 763-769.

参考文献

[1] RAZIN S,HAYFLICK L.Highlights of Mycoplasma research-An historical perspective[J].Biologicals,2010,38(2):183-190.
[2] KHAN F A,RASHEED M A,FAISAL M,et al.Proteomics analysis and its role in elucidation of functionally significant proteins in Mycoplasma bovis[J].Microbial Pathogenesis,2017,111:50-59.
[3] BÜRKI S,FREY J,PILO P.Virulence,persistence and dissemination of Mycoplasma bovis[J].Veterinary Microbiology,2015,179(1-2):15-22.
[4] CASWELL J L,ARCHAMBAULT M. Mycoplasma bovis pneumonia in cattle[J]. Animal Health Research Reviews,2007,8(2):161-186.
[5] 李岩,姚永进,范伟兴,等.新疆地区规模化奶牛场牛支原体流行病学调查[J].中国动物传染病学报,2013,21(5):68-71. LI Y,YAO Y J,FAN W X,et al.Investigation into Mycoplasma bovis infection on large-scale dairy farms in Xinjiang[J].Chinese Journal of Animal Infectious Diseases, 2013,21(5):68-71.(in Chinese)
[6] LYSNYANSKY I,AYLING R D.Mycoplasma bovis:Mechanisms of resistance and trends in antimicrobial susceptibility[J].Frontiers in Microbiology,2016,7:595.
[7] CHO Y S,LEE H S,LIM S K,et al.Safety and efficacy testing of a novel multivalent bovine bacterial respiratory vaccine composed of five bacterins and two immunogens[J].Journal of Veterinary Medical Science,2008,70(9):959-964.
[8] HOWARD C J,STOTT E J,THOMAS L H,et al.Protection against respiratory disease in calves induced by vaccines containing respiratory syncytial virus,parainfluenza type 3 virus,Mycoplasma bovis and M. dispar[J].Veterinary Record,1987,121(16):372-376.
[9] URBANECK D,LEIBIG F,FORBRIG T H,et al.Erfanryngsbericht zur Anwedung bestandsspezifischer impfstoffe genen respiratorische infektionen mit beteiligung von Mycoplasma bovis in einem mastrindegrossbestand[J].Der Praktishe Tierarzt,2000,81:756-763.
[10] NICHOLAS R A,AYLING R D,STIPKOVITS L P.An experimental vaccine for calf pneumonia caused by Mycoplasma bovis:Clinical,cultural,serological and pathological findings[J].Vaccine,2002,20(29-30):3569-3575.
[11] DUDEK K,BEDNAREK D,AYLING R D,et al.An experimental vaccine composed of two adjuvants gives protection against Mycoplasma bovis in calves[J].Vaccine,2016,34(27):3051-3058.
[12] ZHANG R,HAN X,CHEN Y,et al.Attenuated Mycoplasma bovis strains provide protection against virulent infection in calves[J].Vaccine,2014,32(25):3107-3114.
[13] NICHOLAS R A,AYLING R D,MCAULIFFE L.Vaccines for Mycoplasma diseases in animals and man[J].Journal of Comparative Pathology,2009,140(2-3):85-96.
[14] THORNS C J,BOUGHTON E.Effect of serial passages through liquid medium on the virulence of Mycoplasma bovis for the mouse mammary gland[J].Research in Veterinary Science,1980,29(3):328-332.
[15] KHAN L A,MILES R J,NICHOLAS R A.Hydrogen peroxide production by Mycoplasma bovis and Mycoplasma agalactiae and effect of in vitro passage on a Mycoplasma bovis strain producing high levels of H₂O₂[J].Veterinary Research Communications,2005,29(3):181-188.
[16] NICHOLAS R A J,AYLING R D,WOODGER N,et al.Mycoplasmas in adult cattle:Bugs worth bothering about?[J]. Irish Veterinary Journal,2006,59(5):301-304.
[17] SOEHNLEN M K,AYDIN A,LENGERICH E J,et al.Blinded,controlled field trial of two commercially available Mycoplasma bovis bacterin vaccines in veal calves[J].Vaccine,2011,29(33):5347-5354.
[18] KENSIL C R,PATEL U,LENNICK M,et al.Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex[J].Journal of Immunology,1991,146(2):431-437.
[19] BRYSON T D G,BALL,H J,FOSTER F,et al.Enhanced severity of induced Mycoplasma bovis pneumonia in calves following immunisation with different antigenic extracts[J].Reaearch in Veterinary Science,2002,72(2):19.
[20] PEREZ-CASAL J,PRYSLIAK T.Detection of antibodies against the Mycoplasma bovis glyceraldehyde-3-phosphate dehydrogenase protein in beef cattle[J].Microbial Pathogenesis,2007,43(5-6):189-197.
[21] PRYSLIAK T,MERWE J V D,PEREZ-CASAL J.Vaccination with recombinant Mycoplasma bovis GAPDH results in a strong humoral immune response but does not protect feedlot cattle from an experimental challenge with M.bovis[J].Microbial Pathogenesis,2013,55:1-8.
[22] MULONGO M,PRYSLIAK T,PEREZ-CASAL J.Vaccination of feedlot cattle with extracts and membrane fractions from two Mycoplasma bovis isolates results in strong humoral immune responses but does not protect against an experimental challenge[J].Vaccine,2013,31(10):1406-1412.
[23] PRYSLIAK T,PEREZ-CASAL J.Immune responses to Mycoplasma bovis proteins formulated with different adjuvants[J].Canadian Journal of Microbiology,2016,62(6):492-504.
[24] SACHSE K,HELBIG J H,LYSNYANSKY I,et al.Epitope mapping of immunogenic and adhesive structures in repetitive domains of Mycoplasma bovis variable surface lipoproteins[J].Infection and Immunity,2000,68(2):680-687.
[25] SONG Z,LI Y,LIU Y,et al.alpha-Enolase,an adhesion-related factor of Mycoplasma bovis[J].PLoS One,2012,7(6):e38836.
[26] THOMAS A,SACHSE K,DIZIER I,et al.Adherence to various host cell lines of Mycoplasma bovis strains differing in pathogenic and cultural features[J].Veterinary Microbiology,2003,91(2-3):101-113.
[27] ROBINO P,ALBERTI A,PITTAU M,et al.Genetic and antigenic characterization of the surface lipoprotein P48 of Mycoplasma bovis[J].Veterinary Microbiology,2005,109(3-4):201-209.
[28] FODDAI A,IDINI G,FUSCO M,et al.Rapid differential diagnosis of Mycoplasma agalactiae and Mycoplasma bovis based on a multiplex-PCR and a PCR-RFLP[J].Mocular and Cellular Probes,2005,19(3):207-212.
[29] VANDER B T J,ROSENBUSCH R F.Characterization of the immune response to Mycoplasma bovis lung infection[J].Veterinary Immunology and Immunopathology,2003,94(1-2):23-33.
[30] HERMEYER K,BUCHENAU I,THOMASMEYER A,et al.Chronic pneumonia in calves after experimental infection with Mycoplasma bovis strain 1067:Characterization of lung pathology,persistence of variable surface protein antigens and local immune response[J].Acta Veterinary Scandinavica,2012,54(9):1-11.
[31] JIMBO S,SULEMAN M,MAINA T,et al.Effect of Mycoplasma bovis on bovine neutrophils[J].Veterinary Immunology and Immunopathology,2017,188(6):27-33.
[32] GONDAIRA S,HIGUCHI H,NISHI K,et al.Mycoplasma bovis escapes bovine neutrophil extracellular traps[J].Veterinary Microbiology,2017,199(2):68-73.
[33] MERWE J V D,PRYSLIAK T,PEREZ-CASAL J.Invasion of bovine peripheral blood mononuclear cells and erythrocytes by Mycoplasma bovis[J].Infection and Immunity,2010,78(11):4570-4578.
[34] VANDEN B T,ROSENBUSCH R F. Mycoplasma bovis induces apoptosis of bovine lymphocytes[J].Fems Immunology and Medical Microbiology,2002,32(2):97-103.
[35] MULONGO M,PRYSLIAK T,SCRUTEN E,et al.In vitro infection of bovine monocytes with Mycoplasma bovis delays apoptosis and suppresses production of gamma interferon and tumor necrosis factor alpha but not interleukin-10[J].Infection and Immunity,2014,82(1):62-71.
[36] 杨海,王芳宇.DNA疫苗的研究进展[J].中国畜牧兽医,2013,40(1):72-76. YANG H,WANG F Y.Research progress of DNA vaccine[J].China Animal Husbandry & Veterinary Medicine,2013,40(1):72-76.(in Chinese)